|
Volumn 16, Issue 5, 2012, Pages 554-556
|
SRD5A3-CDG: A patient with a novel mutation
|
Author keywords
Novel mutation; Steroid 5 alpha reductase type 3 deficiency
|
Indexed keywords
PROTEIN C;
STEROID 5ALPHA REDUCTASE;
STEROID 5ALPHA REDUCTASE 3;
TRANSFERRIN;
UNCLASSIFIED DRUG;
ARTICLE;
BODY HEIGHT;
BODY WEIGHT;
BRAIN ATROPHY;
CARDIOMEGALY;
CASE REPORT;
CEREBELLAR ATAXIA;
CHILD;
CONGENITAL DISORDER OF GLYCOSYLATION TYPE 1;
CONGESTIVE CARDIOMYOPATHY;
CONVERGENT STRABISMUS;
CRYPTORCHISM;
EAR DYSPLASIA;
ECHOCARDIOGRAPHY;
EYE MALFORMATION;
GENE MUTATION;
GENE SEQUENCE;
HEAD CIRCUMFERENCE;
HEART LEFT VENTRICLE FAILURE;
HOMOZYGOSITY;
HUMAN;
LIP MALFORMATION;
MALE;
MUSCLE HYPOTONIA;
MUSCLE TONE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
NYSTAGMUS;
PAIN THRESHOLD;
PRESCHOOL CHILD;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
PSYCHOMOTOR RETARDATION;
SKIN DEFECT;
THORAX RADIOGRAPHY;
TURKEY (REPUBLIC);
VISUAL IMPAIRMENT;
3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE;
CEREBELLAR ATAXIA;
CEREBELLUM;
CHILD, PRESCHOOL;
CONGENITAL DISORDERS OF GLYCOSYLATION;
HOMOZYGOTE;
HUMANS;
MALE;
MEMBRANE PROTEINS;
MUTATION;
NYSTAGMUS, PATHOLOGIC;
PSYCHOMOTOR DISORDERS;
|
EID: 84865149514
PISSN: 10903798
EISSN: 15322130
Source Type: Journal
DOI: 10.1016/j.ejpn.2011.12.011 Document Type: Article |
Times cited : (30)
|
References (10)
|